{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:34:54Z","timestamp":1793046894325,"version":"4.5.0"},"reference-count":176,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005347","name":"American Association for the Study of Liver Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cmghjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2027]]},"DOI":"10.1016\/j.jcmgh.2026.101899","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T15:39:02Z","timestamp":1789832342000},"page":"101899","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic Dysfunction-Associated Steatohepatitis: Is There Evidence for Fractured CD4+ T-Cell Tolerance in the Immunopathogenesis"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4725-2574","authenticated-orcid":false,"given":"Abigail E.","family":"Russi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9924-7921","authenticated-orcid":false,"given":"Brian J.","family":"DeBosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcmgh.2026.101899_bib1","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib2","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000251","article-title":"The burden of nonalcoholic fatty liver disease (NAFLD) is rapidly growing in every region of the world from 1990 to 2019","volume":"7","author":"Paik","year":"2023","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jcmgh.2026.101899_bib3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2026.101899_bib4","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.54707","article-title":"Estimated burden of metabolic dysfunction-associated steatotic liver disease in US adults, 2020 to 2050","volume":"8","author":"Le","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jcmgh.2026.101899_bib5","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.tem.2024.02.007","article-title":"Current status and future trends of the global burden of MASLD","volume":"35","author":"Miao","year":"2024","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.jcmgh.2026.101899_bib6","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s12325-024-03085-4","article-title":"Understanding MASH: an examination of progression and clinical outcomes by disease severity in the TARGET-NASH database","volume":"42","author":"Luthra","year":"2025","journal-title":"Adv Ther"},{"key":"10.1016\/j.jcmgh.2026.101899_bib7","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.jcmgh.2026.101899_bib8","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2026.101899_bib9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jceh.2015.02.002","article-title":"The riddle of nonalcoholic fatty liver disease: progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis","volume":"5","author":"Sharma","year":"2015","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib10","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/17474124.2018.1460202","article-title":"The relationship between obesity and the severity of non-alcoholic fatty liver disease: systematic review and meta-analysis","volume":"12","author":"Lu","year":"2018","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib11","doi-asserted-by":"crossref","DOI":"10.1111\/liv.70300","article-title":"Clinical and genetic predictors of non-alcoholic steatotic liver disease and fibrosis in lean individuals","volume":"45","author":"Sato-Espinoza","year":"2025","journal-title":"Liver Int"},{"key":"10.1016\/j.jcmgh.2026.101899_bib12","article-title":"Targeting Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): available and future pharmaceutical options","volume":"17","author":"Koullias","year":"2025","journal-title":"Cureus"},{"key":"10.1016\/j.jcmgh.2026.101899_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25115640","article-title":"Metabolic dysfunction-associated steatotic liver disease: from pathogenesis to current therapeutic options","volume":"25","author":"Portincasa","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jcmgh.2026.101899_bib14","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.21965","article-title":"Tolerogenic maturation of liver sinusoidal endothelial cells promotes B7-homolog 1-dependent CD8+ T cell tolerance","volume":"47","author":"Diehl","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2026.101899_bib15","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/82161","article-title":"Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance","volume":"6","author":"Limmer","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.jcmgh.2026.101899_bib16","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/S0016-5085(99)70508-1","article-title":"Induction of cytokine production in naive CD4(+) T cells by antigen-presenting murine liver sinusoidal endothelial cells but failure to induce differentiation toward Th1 cells","volume":"116","author":"Knolle","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2026.101899_bib17","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1189\/jlb.0604332","article-title":"Development and functional consequences of LPS tolerance in sinusoidal endothelial cells of the liver","volume":"77","author":"Uhrig","year":"2005","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib18","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1042\/bj2700205","article-title":"Intracellular transport of endocytosed proteins in rat liver endothelial cells","volume":"270","author":"Kindberg","year":"1990","journal-title":"Biochem J"},{"key":"10.1016\/j.jcmgh.2026.101899_bib19","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jhep.2014.04.027","article-title":"TGF-beta-dependent induction of CD4(+)CD25(+)Foxp3(+) Tregs by liver sinusoidal endothelial cells","volume":"61","author":"Carambia","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib20","doi-asserted-by":"crossref","first-page":"G67","DOI":"10.1152\/ajpgi.00009.2021","article-title":"Sinusoidal endotheliopathy in nonalcoholic steatohepatitis: therapeutic implications","volume":"321","author":"Ibrahim","year":"2021","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib21","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.jhep.2019.02.012","article-title":"Role of liver sinusoidal endothelial cells in non-alcoholic fatty liver disease","volume":"70","author":"Hammoutene","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib22","article-title":"Glycogen synthase kinase 3 activity enhances liver inflammation in MASH","volume":"6","author":"Khoury","year":"2024","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jcmgh.2026.101899_bib23","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41575-018-0020-y","article-title":"Liver sinusoidal endothelial cells - gatekeepers of hepatic immunity","volume":"15","author":"Shetty","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib24","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.cell.2021.12.018","article-title":"Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches","volume":"185","author":"Guilliams","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.jcmgh.2026.101899_bib25","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1080\/17474124.2025.2508963","article-title":"Reviewing the function of macrophages in liver disease","volume":"19","author":"Chen","year":"2025","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108626","article-title":"Dynamic shifts in the composition of resident and recruited macrophages influence tissue remodeling in NASH","volume":"34","author":"Daemen","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.jcmgh.2026.101899_bib27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/978-3-031-65944-7_7","article-title":"Liver macrophage diversity in health and disease","volume":"74","author":"Horn","year":"2024","journal-title":"Results Probl Cell Differ"},{"key":"10.1016\/j.jcmgh.2026.101899_bib28","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1046\/j.1365-2249.1997.d01-959.x","article-title":"Regulation of endotoxin-induced IL-6 production in liver sinusoidal endothelial cells and Kupffer cells by IL-10","volume":"107","author":"Knolle","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib29","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/0168-8278(95)80433-1","article-title":"Human Kupffer cells secrete IL-10 in response to lipopolysaccharide (LPS) challenge","volume":"22","author":"Knolle","year":"1995","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib30","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1136\/gutjnl-2019-318382","article-title":"Myeloid cells in liver and bone marrow acquire a functionally distinct inflammatory phenotype during obesity-related steatohepatitis","volume":"69","author":"Krenkel","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.jcmgh.2026.101899_bib31","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jhep.2007.04.019","article-title":"Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis","volume":"47","author":"Rivera","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib32","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1038\/s41590-025-02255-y","article-title":"Single-cell atlas of human liver and blood immune cells across fatty liver disease stages reveals distinct signatures linked to liver dysfunction and fibrogenesis","volume":"26","author":"Martin","year":"2025","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib33","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.jcmgh.2023.03.002","article-title":"The multifaceted roles of macrophages in NAFLD pathogenesis","volume":"15","author":"Vonderlin","year":"2023","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib34","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/s41586-019-1631-3","article-title":"Resolving the fibrotic niche of human liver cirrhosis at single-cell level","volume":"575","author":"Ramachandran","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jcmgh.2026.101899_bib35","article-title":"The microenvironment in the development of MASLD-MASH-HCC and associated therapeutic in MASH-HCC","volume":"16","author":"Wu","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib36","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/HEP.0000000000000762","article-title":"Neutrophil extracellular traps promote MASH fibrosis by metabolic reprogramming of HSC","volume":"81","author":"Xia","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2026.101899_bib37","doi-asserted-by":"crossref","first-page":"116","DOI":"10.5483\/BMBRep.2024-0058","article-title":"Neutrophils in MASLD and MASH","volume":"58","author":"Shrestha","year":"2025","journal-title":"BMB Rep"},{"key":"10.1016\/j.jcmgh.2026.101899_bib38","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41586-020-2193-0","article-title":"Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells","volume":"581","author":"Campbell","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jcmgh.2026.101899_bib39","doi-asserted-by":"crossref","first-page":"5981","DOI":"10.4049\/jimmunol.1102868","article-title":"Lipopolysaccharide-activated dendritic cells: \u201cexhausted\u201d or alert and waiting?","volume":"188","author":"Abdi","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib40","article-title":"Dynamic immune landscape of NAFLD highlights pDCs as predictive biomarkers for disease progression","volume":"17","author":"Huang","year":"2026","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1379225","article-title":"The role of dendritic cells in MASH: friends or foes?","volume":"15","author":"Pinto","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib42","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1016\/j.cmet.2023.10.009","article-title":"The bidirectional immune crosstalk in metabolic dysfunction-associated steatotic liver disease","volume":"35","author":"Sawada","year":"2023","journal-title":"Cell Metab"},{"key":"10.1016\/j.jcmgh.2026.101899_bib43","first-page":"3213","article-title":"In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-alpha","volume":"119","author":"Connolly","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jcmgh.2026.101899_bib44","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/hep.26267","article-title":"Dendritic cells limit fibroinflammatory injury in nonalcoholic steatohepatitis in mice","volume":"58","author":"Henning","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2026.101899_bib45","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1053\/j.gastro.2012.06.003","article-title":"Dendritic cell populations with different concentrations of lipid regulate tolerance and immunity in mouse and human liver","volume":"143","author":"Ibrahim","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2026.101899_bib46","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/s41591-021-01344-3","article-title":"XCR1(+) type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis","volume":"27","author":"Deczkowska","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.jcmgh.2026.101899_bib47","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1038\/s41467-025-57574-3","article-title":"Microbiota-derived H(2)S induces c-kit(+) cDC1 autophagic cell death and liver inflammation in metabolic dysfunction-associated steatohepatitis","volume":"16","author":"Song","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcmgh.2026.101899_bib48","doi-asserted-by":"crossref","first-page":"5549","DOI":"10.4049\/jimmunol.1003917","article-title":"Hepatic stellate cells function as regulatory bystanders","volume":"186","author":"Ichikawa","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib49","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1089\/ars.2014.6108","article-title":"Myeloperoxidase-hepatocyte-stellate cell cross talk promotes hepatocyte injury and fibrosis in experimental nonalcoholic steatohepatitis","volume":"23","author":"Pulli","year":"2015","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.jcmgh.2026.101899_bib50","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s12072-018-9882-x","article-title":"Linking the gut and liver: crosstalk between regulatory T cells and mucosa-associated invariant T cells","volume":"12","author":"Atif","year":"2018","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jcmgh.2026.101899_bib51","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00281-022-00949-1","article-title":"MAIT cells in liver inflammation and fibrosis","volume":"44","author":"Mehta","year":"2022","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib52","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1038\/s41467-018-04450-y","article-title":"Mucosal-associated invariant T cells are a profibrogenic immune cell population in the liver","volume":"9","author":"Hegde","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcmgh.2026.101899_bib53","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1038\/s41467-023-37453-5","article-title":"MAIT cell inhibition promotes liver fibrosis regression via macrophage phenotype reprogramming","volume":"14","author":"Mabire","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcmgh.2026.101899_bib54","doi-asserted-by":"crossref","DOI":"10.1097\/HEP.0000000000001371","article-title":"Metabolic reprogramming of immune cells in MASH","author":"Ma","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2026.101899_bib55","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12943-025-02370-2","article-title":"Single-cell transcriptome reveals the reprogramming of immune microenvironment during the transition from MASH to HCC","volume":"24","author":"Huang","year":"2025","journal-title":"Mol Cancer"},{"key":"10.1016\/j.jcmgh.2026.101899_bib56","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.4049\/jimmunol.1202814","article-title":"Tim-3\/galectin-9 regulate the homeostasis of hepatic NKT cells in a murine model of nonalcoholic fatty liver disease","volume":"190","author":"Tang","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib57","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4291\/wjgp.v5.i2.107","article-title":"Role of gamma-delta T cells in liver inflammation and fibrosis","volume":"5","author":"Hammerich","year":"2014","journal-title":"World J Gastrointest Pathophysiol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib58","article-title":"Tissue-resident memory T cells in chronic liver diseases: Phenotype, development and function","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib59","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1136\/gutjnl-2020-323771","article-title":"The human liver microenvironment shapes the homing and function of CD4(+) T-cell populations","volume":"71","author":"Wiggins","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.jcmgh.2026.101899_bib60","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.153831","article-title":"Multicytokine-producing CD4+ T cells characterize the livers of patients with NASH","volume":"8","author":"Woestemeier","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.jcmgh.2026.101899_bib61","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.70091","article-title":"Fatty acid metabolism-an emerging regulatory node in T-cell immunometabolism","volume":"15","author":"Arenberg","year":"2026","journal-title":"Clin Transl Immunology"},{"key":"10.1016\/j.jcmgh.2026.101899_bib62","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nature12726","article-title":"Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation","volume":"504","author":"Arpaia","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.jcmgh.2026.101899_bib63","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature12721","article-title":"Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells","volume":"504","author":"Furusawa","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.jcmgh.2026.101899_bib64","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/hep.31056","article-title":"Increased liver localization of lipopolysaccharides in human and experimental NAFLD","volume":"72","author":"Carpino","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2026.101899_bib65","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s41590-024-02075-6","article-title":"Terminal differentiation and persistence of effector regulatory T cells essential for preventing intestinal inflammation","volume":"26","author":"Dikiy","year":"2025","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib66","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/ni1428","article-title":"Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice","volume":"8","author":"Kim","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib67","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2536314123","article-title":"Regulatory T cells safeguard liver health during metabolic-associated steatohepatitis","volume":"123","author":"Hanna","year":"2026","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcmgh.2026.101899_bib68","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib69","doi-asserted-by":"crossref","DOI":"10.3390\/cells15020165","article-title":"Western diet dampens T regulatory cell function to fuel hepatic inflammation in metabolic dysfunction-associated steatotic liver disease","volume":"15","author":"Chaudhary","year":"2026","journal-title":"Cells"},{"key":"10.1016\/j.jcmgh.2026.101899_bib70","doi-asserted-by":"crossref","DOI":"10.1111\/liv.70421","article-title":"Tregs with high CD29 expression promote cell adhesion and contribute to the malignant transformation of MASLD","volume":"45","author":"Lu","year":"2025","journal-title":"Liver Int"},{"key":"10.1016\/j.jcmgh.2026.101899_bib71","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.immuni.2024.01.009","article-title":"Amphiregulin from regulatory T cells promotes liver fibrosis and insulin resistance in non-alcoholic steatohepatitis","volume":"57","author":"Savage","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.jcmgh.2026.101899_bib72","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.jhep.2025.05.032","article-title":"Bile acids engage the SIPR-STAT3 signaling axis to modulate regulatory T cell responses in fibrosing cholangiopathies","volume":"83","author":"Kudira","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib73","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4049\/jimmunol.1501175","article-title":"Progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis is marked by a higher frequency of Th17 cells in the liver and an increased Th17\/resting regulatory T cell ratio in peripheral blood and in the liver","volume":"196","author":"Rau","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib74","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.1038\/s41598-021-84674-z","article-title":"Hepatic lymphocytes involved in the pathogenesis of pediatric and adult non-alcoholic fatty liver disease","volume":"11","author":"Cairoli","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcmgh.2026.101899_bib75","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1597204","article-title":"Increased frequencies of human Th-17 CD4+ T-cells and decreased T-regulatory cells in patients with early and advanced metabolic dysfunction-associated steatotic liver disease","volume":"16","author":"Supruniuk","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib76","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.cell.2015.03.005","article-title":"Immunosurveillance of the liver by intravascular effector CD8(+) T cells","volume":"161","author":"Guidotti","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.jcmgh.2026.101899_bib77","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s41586-021-03233-8","article-title":"Auto-aggressive CXCR6(+) CD8 T cells cause liver immune pathology in NASH","volume":"592","author":"Dudek","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jcmgh.2026.101899_bib78","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jhep.2023.02.033","article-title":"Role of immune responses in the development of NAFLD-associated liver cancer and prospects for therapeutic modulation","volume":"79","author":"Yahoo","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib79","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/HEP.0000000000000971","article-title":"Ag-driven CD8 + T cell clonal expansion is a prominent feature of MASH in humans and mice","volume":"81","author":"Burtis","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2026.101899_bib80","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1017\/S0029665111000565","article-title":"Fats, inflammation and insulin resistance: insights to the role of macrophage and T-cell accumulation in adipose tissue","volume":"70","author":"Harford","year":"2011","journal-title":"Proc Nutr Soc"},{"key":"10.1016\/j.jcmgh.2026.101899_bib81","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/ATVBAHA.113.302077","article-title":"Essential role of CD11a in CD8+ T-cell accumulation and activation in adipose tissue","volume":"34","author":"Jiang","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib82","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.680944","article-title":"High fat diet-induced CD8(+) T cells in adipose tissue mediate macrophages to sustain low-grade chronic inflammation","volume":"12","author":"Kiran","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib83","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jhep.2009.10.019","article-title":"CD8+ T cells drive adipose tissue inflammation--a novel clue for NASH pathogenesis?","volume":"52","author":"Popov","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib84","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3389\/fendo.2020.00257","article-title":"Macrophages mediate increased CD8 T cell inflammation during weight loss in formerly obese mice","volume":"11","author":"Surendar","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jcmgh.2026.101899_bib85","article-title":"The multifaceted roles of B lymphocytes in metabolic dysfunction-associated steatotic liver disease","volume":"15","author":"Li","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib86","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jhep.2023.04.037","article-title":"Intestinal B cells license metabolic T-cell activation in NASH microbiota\/antigen-independently and contribute to fibrosis by IgA-FcR signalling","volume":"79","author":"Kotsiliti","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib87","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/hep.31755","article-title":"Microbiota-driven activation of intrahepatic B cells aggravates NASH through innate and adaptive signaling","volume":"74","author":"Barrow","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2026.101899_bib88","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.freeradbiomed.2018.06.015","article-title":"B2-Lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD)","volume":"124","author":"Bruzzi","year":"2018","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jcmgh.2026.101899_bib89","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.580968","article-title":"CD4(+) T cells mediate the development of liver fibrosis in high fat diet-induced NAFLD in humanized mice","volume":"11","author":"Her","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib90","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1034\/j.1600-0528.2002.017408.x","article-title":"Local control of the immune response in the liver","volume":"174","author":"Knolle","year":"2000","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jcmgh.2026.101899_bib91","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/j.immuni.2022.10.006","article-title":"Regulatory T cells as metabolic sensors","volume":"55","author":"de Candia","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.jcmgh.2026.101899_bib92","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nri2858","article-title":"Antigen-presenting cell function in the tolerogenic liver environment","volume":"10","author":"Thomson","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib93","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S1471-4906(01)01957-3","article-title":"Neighborhood politics: the immunoregulatory function of organ-resident liver endothelial cells","volume":"22","author":"Knolle","year":"2001","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib94","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0092-8674(02)00827-9","article-title":"IRAK-M is a negative regulator of toll-like receptor signaling","volume":"110","author":"Kobayashi","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.jcmgh.2026.101899_bib95","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/s41577-026-01288-0","article-title":"Kupffer cells in liver homeostasis and disease: from immune sentinels to metabolic gatekeepers","volume":"26","author":"Araujo David","year":"2026","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib96","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aaj1996","article-title":"Up-regulation of LFA-1 allows liver-resident memory T cells to patrol and remain in the hepatic sinusoids","volume":"2","author":"McNamara","year":"2017","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib97","doi-asserted-by":"crossref","DOI":"10.1126\/science.aan5931","article-title":"Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells","volume":"360","author":"Ma","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.jcmgh.2026.101899_bib98","article-title":"Hepatic immune environment differences among common mouse strains in models of MASH and liver cancer","volume":"7","author":"Huang","year":"2025","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jcmgh.2026.101899_bib99","doi-asserted-by":"crossref","DOI":"10.3390\/biom14040476","article-title":"Innate immunity and MASLD","volume":"14","author":"Meyer","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.jcmgh.2026.101899_bib100","article-title":"Understanding the complex macrophage landscape in MASLD","volume":"6","author":"De Ponti","year":"2024","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jcmgh.2026.101899_bib101","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.immuni.2022.08.002","article-title":"Liver macrophages in health and disease","volume":"55","author":"Guilliams","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.jcmgh.2026.101899_bib102","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1007\/s10875-011-9571-1","article-title":"Altered phenotype and functionality of circulating immune cells characterize adult patients with nonalcoholic steatohepatitis","volume":"31","author":"Inzaugarat","year":"2011","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib103","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ccell.2014.09.003","article-title":"Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes","volume":"26","author":"Wolf","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jcmgh.2026.101899_bib104","article-title":"From model to man: understanding Tregs\u2019 dual role in MASLD","volume":"7","author":"Dywicki","year":"2025","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jcmgh.2026.101899_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.141919","article-title":"Bulk transcriptome and single-nucleus RNA sequencing analyses highlight the role of recombination activating 1 in non-alcoholic fatty liver disease","volume":"307","author":"Luo","year":"2025","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib106","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/hep4.1807","article-title":"The detrimental role of regulatory T cells in nonalcoholic steatohepatitis","volume":"6","author":"Dywicki","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jcmgh.2026.101899_bib107","article-title":"PNPLA3 I148M variant links to adverse metabolic traits in MASLD during fasting and feeding","volume":"7","author":"Jegodzinski","year":"2025","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jcmgh.2026.101899_bib108","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jhep.2025.09.013","article-title":"Genetic and non-genetic drivers of histological progression and regression in MASLD","volume":"84","author":"Vilar-Gomez","year":"2026","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib109","doi-asserted-by":"crossref","DOI":"10.1097\/HEP.0000000000001772","article-title":"CD4+ T cells promote fibrosis during metabolic dysfunction-associated steatohepatitis","author":"Valenzuela-Perez","year":"2026","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2026.101899_bib110","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.jhep.2020.05.047","article-title":"Blocking integrin alpha(4)beta(7)-mediated CD4 T cell recruitment to the intestine and liver protects mice from western diet-induced non-alcoholic steatohepatitis","volume":"73","author":"Rai","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib111","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aba4448","article-title":"Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis","volume":"12","author":"Govaere","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jcmgh.2026.101899_bib112","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-48746-5","article-title":"Gene expression predicts histological severity and reveals distinct molecular profiles of nonalcoholic fatty liver disease","volume":"9","author":"Hoang","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcmgh.2026.101899_bib113","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202302517","article-title":"Comprehensive meta-analysis reveals distinct gene expression signatures of MASLD progression","volume":"7","author":"Piras","year":"2024","journal-title":"Life Sci Alliance"},{"key":"10.1016\/j.jcmgh.2026.101899_bib114","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143380","article-title":"Peripheral and hepatic vein cytokine levels in correlation with Non-Alcoholic Fatty Liver Disease (NAFLD)-related metabolic, histological, and haemodynamic features","volume":"10","author":"Vonghia","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jcmgh.2026.101899_bib115","article-title":"CD4+ T cells promote fibrosis during metabolic dysfunction-associated steatohepatitis","author":"Valenzuela-P\u00e9rez","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.jcmgh.2026.101899_bib116","article-title":"Myeloid cell MHC I expression drives CD8(+) T cell activation in nonalcoholic steatohepatitis","volume":"14","author":"Adams","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib117","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/nm.1964","article-title":"CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity","volume":"15","author":"Nishimura","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.jcmgh.2026.101899_bib118","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.4049\/jimmunol.175.2.1047","article-title":"Hepatocytes express abundant surface class I MHC and efficiently use transporter associated with antigen processing, tapasin, and low molecular weight polypeptide proteasome subunit components of antigen processing and presentation pathway","volume":"175","author":"Chen","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib119","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/344742a0","article-title":"Beta 2-microglobulin deficient mice lack CD4-8+ cytolytic T cells","volume":"344","author":"Zijlstra","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.jcmgh.2026.101899_bib120","doi-asserted-by":"crossref","first-page":"G211","DOI":"10.1152\/ajpgi.00040.2019","article-title":"CD8(+) T cells regulate liver injury in obesity-related nonalcoholic fatty liver disease","volume":"318","author":"Breuer","year":"2020","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib121","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/hep4.1041","article-title":"Hepatic natural killer T-cell and CD8+ T-cell signatures in mice with nonalcoholic steatohepatitis","volume":"1","author":"Bhattacharjee","year":"2017","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jcmgh.2026.101899_bib122","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41586-021-03362-0","article-title":"NASH limits anti-tumour surveillance in immunotherapy-treated HCC","volume":"592","author":"Pfister","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jcmgh.2026.101899_bib123","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1002\/hep.31889","article-title":"The emerging role of B cells in the pathogenesis of NAFLD","volume":"74","author":"Barrow","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2026.101899_bib124","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1111\/jcmm.14232","article-title":"Mesenteric adipose tissue B lymphocytes promote local and hepatic inflammation in non-alcoholic fatty liver disease mice","volume":"23","author":"Wu","year":"2019","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.jcmgh.2026.101899_bib125","doi-asserted-by":"crossref","first-page":"58","DOI":"10.4049\/jimmunol.1900539","article-title":"The tetraspanin CD53 regulates early B cell development by promoting IL-7R signaling","volume":"204","author":"Greenberg","year":"2020","journal-title":"J Immunol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102835","article-title":"The tetraspanin transmembrane protein CD53 mediates dyslipidemia and integrates inflammatory and metabolic signaling in hepatocytes","volume":"299","author":"Higgins","year":"2023","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jcmgh.2026.101899_bib127","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/89775","article-title":"IgA production without mu or delta chain expression in developing B cells","volume":"2","author":"Macpherson","year":"2001","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib128","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.immuni.2023.01.004","article-title":"Principles of regulatory T cell function","volume":"56","author":"Dikiy","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.jcmgh.2026.101899_bib129","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jcmgh.2026.101899_bib130","article-title":"Pleiotropic immunoregulation by bile acids in pathophysiology","volume":"17","author":"Lin","year":"2026","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib131","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41586-019-1785-z","article-title":"Bile acid metabolites control T(H)17 and T(reg) cell differentiation","volume":"576","author":"Hang","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jcmgh.2026.101899_bib132","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41586-019-1865-0","article-title":"Microbial bile acid metabolites modulate gut RORgamma(+) regulatory T cell homeostasis","volume":"577","author":"Song","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jcmgh.2026.101899_bib133","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.chom.2021.07.013","article-title":"A bacterial bile acid metabolite modulates T(reg) activity through the nuclear hormone receptor NR4A1","volume":"29","author":"Li","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jcmgh.2026.101899_bib134","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/s41586-022-04480-z","article-title":"Human gut bacteria produce Tau(Eta)17-modulating bile acid metabolites","volume":"603","author":"Paik","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jcmgh.2026.101899_bib135","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41586-021-03421-6","article-title":"CAR directs T cell adaptation to bile acids in the small intestine","volume":"593","author":"Chen","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jcmgh.2026.101899_bib136","doi-asserted-by":"crossref","DOI":"10.3390\/biom13091356","article-title":"Alterations in circulating bile acids in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis","volume":"13","author":"Lai","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.jcmgh.2026.101899_bib137","doi-asserted-by":"crossref","DOI":"10.3390\/molecules30153066","article-title":"Multifaceted interactions between bile acids, their receptors, and MASH: from molecular mechanisms to clinical therapeutics","volume":"30","author":"Tang","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.jcmgh.2026.101899_bib138","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/oby.21855","article-title":"Metabolomic profiling distinction of human nonalcoholic fatty liver disease progression from a common rat model","volume":"25","author":"Han","year":"2017","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.jcmgh.2026.101899_bib139","article-title":"A gut microbiota-independent mechanism shapes the bile acid pool in mice with MASH","volume":"6","author":"Gillard","year":"2024","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jcmgh.2026.101899_bib140","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1016\/j.cell.2024.03.034","article-title":"Gut symbionts alleviate MASH through a secondary bile acid biosynthetic pathway","volume":"187","author":"Nie","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.jcmgh.2026.101899_bib141","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1084\/jem.20151159","article-title":"T cell metabolism drives immunity","volume":"212","author":"Buck","year":"2015","journal-title":"J Exp Med"},{"key":"10.1016\/j.jcmgh.2026.101899_bib142","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.4049\/jimmunol.0903586","article-title":"Glutamine uptake and metabolism are coordinately regulated by ERK\/MAPK during T lymphocyte activation","volume":"185","author":"Carr","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib143","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cmet.2014.05.004","article-title":"The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function","volume":"20","author":"Macintyre","year":"2014","journal-title":"Cell Metab"},{"key":"10.1016\/j.jcmgh.2026.101899_bib144","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.immuni.2016.01.028","article-title":"The proteomic landscape of human ex vivo regulatory and conventional T cells reveals specific metabolic requirements","volume":"44","author":"Procaccini","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.jcmgh.2026.101899_bib145","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1126\/science.1241165","article-title":"The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis","volume":"341","author":"Smith","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.jcmgh.2026.101899_bib146","doi-asserted-by":"crossref","DOI":"10.3390\/nu12040951","article-title":"Oral supplementation of sodium butyrate attenuates the progression of non-alcoholic steatohepatitis","volume":"12","author":"Baumann","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.jcmgh.2026.101899_bib147","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1177\/2050640618804444","article-title":"Fecal SCFAs and SCFA-producing bacteria in gut microbiome of human NAFLD as a putative link to systemic T-cell activation and advanced disease","volume":"6","author":"Rau","year":"2018","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.jcmgh.2026.101899_bib148","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nature16969","article-title":"NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis","volume":"531","author":"Ma","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jcmgh.2026.101899_bib149","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1136\/gut.28.10.1221","article-title":"Short chain fatty acids in human large intestine, portal, hepatic and venous blood","volume":"28","author":"Cummings","year":"1987","journal-title":"Gut"},{"key":"10.1016\/j.jcmgh.2026.101899_bib150","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.628453","article-title":"Butyrate shapes immune cell fate and function in allergic asthma","volume":"12","author":"Yip","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib151","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s40168-021-01125-7","article-title":"Commensal microbe-derived acetate suppresses NAFLD\/NASH development via hepatic FFAR2 signalling in mice","volume":"9","author":"Aoki","year":"2021","journal-title":"Microbiome"},{"key":"10.1016\/j.jcmgh.2026.101899_bib152","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/39614","article-title":"A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis","volume":"389","author":"Groux","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.jcmgh.2026.101899_bib153","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.immuni.2018.12.001","article-title":"The biology of T regulatory type 1 cells and their therapeutic application in immune-mediated diseases","volume":"49","author":"Roncarolo","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.jcmgh.2026.101899_bib154","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/s41586-022-04916-6","article-title":"Immune tolerance of food is mediated by layers of CD4(+) T cell dysfunction","volume":"607","author":"Hong","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jcmgh.2026.101899_bib155","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113323","article-title":"Kruppel-like factor 2+ CD4 T cells avert microbiota-induced intestinal inflammation","volume":"42","author":"Shao","year":"2023","journal-title":"Cell Rep"},{"key":"10.1016\/j.jcmgh.2026.101899_bib156","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2519393123","article-title":"Maternal Kruppel-Like Factor 2 (KLF2)+ CD4 T cells promote fertility and fetal tolerance","volume":"123","author":"Nguyen","year":"2026","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcmgh.2026.101899_bib157","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1002\/hep.27254","article-title":"Immune tolerance in liver disease","volume":"60","author":"Crispe","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2026.101899_bib158","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cmet.2026.02.018","article-title":"The many pathways driving liver inflammation in MASH","volume":"38","author":"Tilg","year":"2026","journal-title":"Cell Metab"},{"key":"10.1016\/j.jcmgh.2026.101899_bib159","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jhep.2025.10.017","article-title":"The role of liver sinusoidal endothelial cells in liver diseases: Key players in health and pathology","volume":"84","author":"Felli","year":"2026","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib160","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut-liver axis in liver disease: Pathophysiological basis for therapy","volume":"72","author":"Albillos","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib161","doi-asserted-by":"crossref","DOI":"10.3390\/nu14245261","article-title":"The prevalence of small intestinal bacterial overgrowth in patients with non-alcoholic liver diseases: NAFLD, NASH, fibrosis, cirrhosis-a systematic review, meta-analysis and meta-regression","volume":"14","author":"Gudan","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.jcmgh.2026.101899_bib162","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000310","article-title":"Gut microbiota and metabolic biomarkers in metabolic dysfunction-associated steatotic liver disease","volume":"8","author":"Long","year":"2024","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jcmgh.2026.101899_bib163","doi-asserted-by":"crossref","DOI":"10.1172\/JCI186423","article-title":"Metabolic dysfunction-associated steatotic liver disease and the gut microbiome: pathogenic insights and therapeutic innovations","volume":"135","author":"Schnabl","year":"2025","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jcmgh.2026.101899_bib164","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41579-023-00904-3","article-title":"The gut-liver axis and gut microbiota in health and liver disease","volume":"21","author":"Hsu","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib165","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13646","article-title":"Composition of gut microbiota and non-alcoholic fatty liver disease: A systematic review and meta-analysis","volume":"25","author":"Su","year":"2024","journal-title":"Obes Rev"},{"key":"10.1016\/j.jcmgh.2026.101899_bib166","doi-asserted-by":"crossref","first-page":"9988","DOI":"10.1038\/s41598-023-37163-4","article-title":"Characteristics of gut microbiota in patients with metabolic associated fatty liver disease","volume":"13","author":"Yang","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcmgh.2026.101899_bib167","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1002\/hep4.1601","article-title":"Donor fecal microbiota transplantation alters gut microbiota and metabolites in obese individuals with steatohepatitis","volume":"4","author":"Witjes","year":"2020","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jcmgh.2026.101899_bib168","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.759306","article-title":"Effect of fecal microbiota transplantation on non-alcoholic fatty liver disease: a randomized clinical trial","volume":"12","author":"Xue","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib169","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.cell.2009.09.033","article-title":"Induction of intestinal Th17 cells by segmented filamentous bacteria","volume":"139","author":"Ivanov","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.jcmgh.2026.101899_bib170","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jcmgh.2015.01.001","article-title":"Hepatic injury in nonalcoholic steatohepatitis contributes to altered intestinal permeability","volume":"1","author":"Luther","year":"2015","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101899_bib171","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1136\/gut.48.2.206","article-title":"The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis","volume":"48","author":"Wigg","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.jcmgh.2026.101899_bib172","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/hep.22848","article-title":"Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease","volume":"49","author":"Miele","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2026.101899_bib173","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1111\/liv.14696","article-title":"Intestinal permeability in human nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"40","author":"De Munck","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.jcmgh.2026.101899_bib174","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104009","article-title":"Contribution of endotoxin to Th17 bias in patients with non-alcoholic steatohepatitis","volume":"142","author":"Wang","year":"2020","journal-title":"Microb Pathog"},{"key":"10.1016\/j.jcmgh.2026.101899_bib175","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2392864","article-title":"Changes in intestinal permeability and gut microbiota following diet-induced weight loss in patients with metabolic dysfunction-associated steatohepatitis and liver fibrosis","volume":"16","author":"Koutoukidis","year":"2024","journal-title":"Gut Microbes"},{"key":"10.1016\/j.jcmgh.2026.101899_bib176","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/JCI92035","article-title":"Inflammatory mechanisms linking obesity and metabolic disease","volume":"127","author":"Saltiel","year":"2017","journal-title":"J Clin Invest"}],"container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X26001773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X26001773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:37:28Z","timestamp":1793043448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352345X26001773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027]]},"references-count":176,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2027]]}},"alternative-id":["S2352345X26001773"],"URL":"https:\/\/doi.org\/10.1016\/j.jcmgh.2026.101899","relation":{},"ISSN":["2352-345X"],"issn-type":[{"value":"2352-345X","type":"print"}],"subject":[],"published":{"date-parts":[[2027]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic Dysfunction-Associated Steatohepatitis: Is There Evidence for Fractured CD4+ T-Cell Tolerance in the Immunopathogenesis","name":"articletitle","label":"Article Title"},{"value":"Cellular and Molecular Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcmgh.2026.101899","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Gastroenterological Association Institute.","name":"copyright","label":"Copyright"}],"article-number":"101899"}}